Aripiprazole (Abilify)
Aripiprazole (Abilify) explained
Aripiprazole (Abilify) is a dopamine D2 partial agonist atypical antipsychotic used for schizophrenia, bipolar I, adjunctive MDD, and irritability in autism.
FDA ApprovedAripiprazole (Abilify) helps treat
• Schizophrenia
• Bipolar I mania/mixed
• Adjunctive therapy in MDD
• Irritability associated with autism
additional medications
• Lurasidone
• Quetiapine
• Cariprazine
• Psychotherapy/mood stabilizers as indicated
medication risks
• Akathisia/EPS
• Impulse‑control problems (rare warning)
• Neuroleptic malignant syndrome (rare)
• Tardive dyskinesia (long‑term)
side effects
• Akathisia (restlessness)
• Insomnia
• Nausea
• Headache
• Anxiety
FAQs
Q: Why is aripiprazole different?A: Partial agonism may reduce sedation and metabolic burden vs some others.
Q: Any movement risks?
A: Akathisia is relatively common; EPS can occur.
Q: Weight gain?
A: Usually modest but monitor metabolic markers.
Q: Use in depression?
A: Often as an adjunct when antidepressant response is inadequate.
Q: Long‑acting injectables?
A: Yes—LAI formulations are available.